Literature DB >> 7925818

Calcineurin immunoreactivity in Alzheimer's disease.

M L Billingsley1, C Ellis, R L Kincaid, J Martin, M L Schmidt, V M Lee, J Q Trojanowski.   

Abstract

Aberrant phosphorylation of tau is linked to formation of the paired helical filaments (PHF) seen in Alzheimer's disease. Protein kinases such as mitogen-activated protein kinase, and calcium-regulated protein kinases may, in part, be responsible for addition of phosphate groups to serine residues of PHFtau; however, less is known concerning the phosphatases which regulate tau. In this report, we used several well-characterized antibodies to document calcineurin immunoreactivity in brain tissue from patients with Alzheimer's disease. We now report that levels of immunoreactive calcineurin are not significantly altered in neocortex and cerebellum of Alzheimer's patients relative to similar regions of age-matched controls. Immunocytochemical studies indicated that calcineurin immunoreactivity was present in dendrites and perikarya of many different neuronal populations in both control and Alzheimer brain. When specific antibodies against PHFtau were used in double-labeling experiments with anti-calcineurin antibodies, calcineurin immunoreactivity was seen in association with neurofibrillary tangles. However, calcineurin was not seen in all tangle bearing neurons. These data suggest that calcineurin levels per se are not significantly altered in Alzheimer's disease, but that calcineurin is distributed around some neurofibrillary tangles and may play a role in regulation of tau phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925818     DOI: 10.1006/exnr.1994.1056

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 2.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau.

Authors:  A Rahman; I Grundke-Iqbal; K Iqbal
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 4.  Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.

Authors:  M P Mattson; S L Chan
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture.

Authors:  Hafiz Mohmmad Abdul; Irfan Baig; Harry Levine; Rodney P Guttmann; Christopher M Norris
Journal:  Aging Cell       Date:  2010-12-08       Impact factor: 9.304

6.  cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease.

Authors:  G A Jicha; C Weaver; E Lane; C Vianna; Y Kress; J Rockwood; P Davies
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

7.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

8.  Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling.

Authors:  Yaling Yin; Di Gao; Yali Wang; Zhi-Hao Wang; Xin Wang; Jinwang Ye; Dongqin Wu; Lin Fang; Guilin Pi; Ying Yang; Xiao-Chuan Wang; Chengbiao Lu; Keqiang Ye; Jian-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

9.  Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function.

Authors:  Melanie M Pleiss; Pradoldej Sompol; Susan D Kraner; Hafiz Mohmmad Abdul; Jennifer L Furman; Rodney P Guttmann; Donna M Wilcock; Peter T Nelson; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2016-05-20

10.  A role for calcineurin in Alzheimer's disease.

Authors:  Lindsay C Reese; Giulio Taglialatela
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.